ANSM recalls batch of antiepileptic drug Micropakine after patient discovery of non-compliant sachets



[ad_1]

The National Agency for the Safety of Medicines and Health Products (ANSM) is recalling a batch of the antiepileptic drug Micropakine, “after discovery by patients in two boxes of empty sachets and sachets too full with valproate granules at a time”. This is batch No. DM0059 (expiration 03/2022) of Micropakine LP 500 mg, extended release granules in sachet, according to a press release published on Friday, November 27 by ANSM.

Administer the drug with an overfilled sachet “may cause the patient to overdose with valproate”, explains the National Agency for Medicines and Health Product Safety. “Patients are therefore advised to return the boxes of batch DM0059 to their pharmacy for exchange, so as not to interrupt their antiepileptic treatment.”

The manufacturer of this drug, the Sanofi-Aventis France laboratory, in agreement with the ANSM, has also asked pharmacists to contact, by all means at their disposal, patients who may have and / or have used the medicine. of the lot affected by this recall.

[ad_2]
Source link